The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ASND FINANCIAL STATEMENTS

Ascendis Pharma AS — balance sheet, income statement and cash flow trends

ASNDAscendis Pharma AS

🇺🇸 USA · US · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-500 M0500 M1 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue1.1 B €Gross Profit950.9 M € · 90%Operating Income109.5 M € · 10%Pre-tax Income101.1 M € · 10%Net Income to Owners755.8 M € · 72%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue1.1 B €+114.8%
Gross Profit950.9 M €+128.3%
Operating Income109.5 M €—
EBITDA78.1 M €—
Net Income to Owners755.8 M €—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets2.3 B
  • Equity1.4 B €63%
  • Current Liabilities464.7 M €20%
  • Long-term Liabilities384.5 M €17%

Key Figures

YoY change
Total Assets2.3 B €+110.0%
Total Liabilities849.2 M €-33.4%
Total Equity1.4 B €—
Cash & ST Investments811.9 M €+64.3%
Total Debt449.9 M €-43.2%
Net Debt-362 M €-221.3%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-500 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0100 M200 M300 M351.3 M €Operating-13.1 M €Investing-36.9 M €Financing301.4 M €Net Change

Key Figures

YoY change
Operating Cash Flow351.3 M €—
Capital Expenditures14.4 M €+144.9%
Free Cash Flow336.9 M €—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ASND

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.